μ-opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice

Journal of Neuroscience

Volumn 31, Issue 1, 2011, Pages 262-272

  Wiskerke, Joost ^a   Schetters, Dustin ^a   Van Es, Inge E ^a   Van Mourik, Yvar ^a   Den Hollander, Bjørnar R O ^a   Schoffelmeer, Anton N M ^a   Pattij, Tommy ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE; VANOXERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DECISION MAKING; DRUG MECHANISM; IMPULSIVENESS; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; TASK PERFORMANCE;

AMPHETAMINE; ANALGESICS, OPIOID; ANIMALS; ATTENTION; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; IMPULSIVE BEHAVIOR; INHIBITION (PSYCHOLOGY); MALE; MOTIVATION; NALOXONE; NALTREXONE; NARCOTIC ANTAGONISTS; NUCLEUS ACCUMBENS; PEPTIDES; RATS; RATS, WISTAR; REACTION TIME; RECEPTORS, OPIOID, MU; REINFORCEMENT SCHEDULE;

EID: 78650910999     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4794-10.2011     Document Type: Article

References (79)

1. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, Ed 4, Text Revision. Washington, DC: American Psychiatric Association.
2. Berendse HW, Galis-de Graaf Y, Groenewegen HJ (1992) Topographical organization and relationship with ventral striatal compartments of pre-frontal corticostriatal projections in the rat. J Comp Neurol 316:314-347.
3. Boettiger CA, Kelley EA, Mitchell JM, D'Esposito M, Fields HL (2009) Now or later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacol Biochem Behav 93:291-299.
4. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ (2001) Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 292:2499-2501.
5. Christakou A, Robbins TW, Everitt BJ (2004) Prefrontal cortical-ventral striatal interactions involved in affective modulation of attentional performance: implications for corticostriatal circuit function. J Neurosci 24:773-780.
6. Cole BJ, Robbins TW (1987) Amphetamine impairs the discriminative performance of rats with dorsal noradrenergic bundle lesions on a 5-choice serial reaction time task: new evidence for central dopaminergic-noradrenergic interactions. Psychopharmacology (Berl) 91:458-466.
7. Cole BJ, Robbins TW (1989) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33:165-179.
8. Cota D, Tschöp MH, Horvath TL, Levine AS (2006) Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res Rev 51:85-107.
9. Devine DP, Leone P, Pocock D, Wise RA (1993) Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 266:1236-1246.
10. Devoto P, Flore G, Pira L, Diana M, Gessa GL (2002) Co-release of nor-adrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal. Psychopharmacology (Berl) 160:220-224. (Pubitemid 34212249)
11. de Wit H, Enggasser JL, Richards JB (2002) Acute administration of D-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacology 27:813-825. (Pubitemid 35335897)
12. Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274-5278.
13. Dilts RP, Kalivas PW (1989) Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res 488:311-327.
14. Doron R, Fridman L, Yadid G (2006) Dopamine-2 receptors in the arcuate nucleus modulate cocaine-seeking behavior. Neuroreport 17:1633-1636. (Pubitemid 44454771)
15. Eagle DM, Bari A, Robbins TW (2008) The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/ no-go tasks. Psychopharmacology (Berl) 199:439-456.
16. Eguchi M (2004) Recent advances in selective opioid receptor agonists and antagonists. Med Res Rev 24:182-212. (Pubitemid 38230679)
17. Elia J, Ambrosini PJ, Rapoport JL (1999) Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340:780-788.
18. Evenden JL (1999) Varieties of impulsivity. Psychopharmacology (Berl) 146:348-361.
19. Feola TW, de Wit H, Richards JB (2000) Effects of D-amphetamine and alcohol on a measure of behavioral inhibition in rats. Behav Neurosci 114:838-848.
20. Fillmore MT, Rush CR, Marczinski CA (2003) Effects of D-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71:143-152.
21. Finley JC, Lindström P, Petrusz P (1981) Immunocytochemical localization of beta-endorphin-containing neurons in the rat brain. Neuroendocrinology 33:28-42.
22. Gonzalez-Nicolini MV, Berglind W, Cole KS, Keogh CL, McGinty JF (2003) Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience 121: 387-398.
23. Häggkvist J, Lindholm S, Franck J (2009) The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat. Behav Brain Res 197:219-224.
24. Heimer L, Zahm DS, Churchill L, Kalivas PW, Wohltmann C (1991) Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 41:89-125.
25. Hirose N, Murakawa K, Takada K, Oi Y, Suzuki T, Nagase H, Cools AR, Koshikawa N (2005) Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience 135:213-225. (Pubitemid 41219750)
26. Hooks MS, Jones DN, Justice JB Jr, Holtzman SG (1992) Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol Biochem Behav 42:765-770.
27. Hurd YL, Herkenham M (1992) Influence of a single injection of cocaine, amphetamine or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res Mol Brain Res 16:97-104.
28. Jayaram-Lindström N, Wennberg P, Hurd YL, Franck J (2004) Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 24:665-669.
29. Jayaram-Lindström N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J (2008) Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 33:1856-1863.
30. Kelley AE, Bakshi VP, Haber SN, Steininger TL, Will MJ, Zhang M (2002) Opioid modulation of taste hedonics within the ventral striatum. Physiol Behav 76:365-377.
31. Kieres AK, Hausknecht KA, Farrar AM, Acheson A, de Wit H, Richards JB (2004) Effects of morphine and naltrexone on impulsive decision making in rats. Psychopharmacology (Berl) 173:167-174.
32. Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S (2004) International consensus statement on attention-deficit/ hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14:11-28.
33. Love TM, Stohler CS, Zubieta JK (2009) Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Arch Gen Psychiatry 66:1124-1134.
34. Madden GJ, Petry NM, Badger GJ, Bickel WK (1997) Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol 5:256-262.
35. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1987) Autoradiographic differentiation of μ, δ, and κ opioid receptors in the rat forebrain and midbrain. J Neurosci 7:2445-2464.
36. Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29.
37. Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL (2006) Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proc Natl Acad Sci U S A 103:2938-2942. (Pubitemid 43306652)
38. Mitchell JM, Tavares VC, Fields HL, D'Esposito M, Boettiger CA (2007) Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls. Neuropsychopharmacology 32:439-449. (Pubitemid 46106950)
39. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC (2001) Psychiatric aspects of impulsivity. Am J Psychiatry 158:1783-1793.
40. Murphy ER, Robinson ES, Theobald DE, Dalley JW, Robbins TW (2008) Contrasting effects of selective lesions of nucleus accumbens core or shell on inhibitory control and amphetamine-induced impulsive behaviour. Eur J Neurosci 28:353-363.
41. Napier TC, Mitrovic I (1999) Opioid modulation of ventral pallidal inputs. Ann N Y Acad Sci 877:176-201.
42. Olive MF, Koenig HN, Nannini MA, Hodge CW (2001) Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J Neurosci 21:RC184(1-5).
43. Olmstead MC, Ouagazzal AM, Kieffer BL (2009) Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task. PLoS One 4:e4410.
44. Paine TA, Tomasiewicz HC, Zhang K, Carlezon WA Jr (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62:687-693. (Pubitemid 47314378)
45. Pattij T, Vanderschuren LJ (2008) The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci 29:192-199.
46. Pattij T, Janssen MC, Vanderschuren LJ, Schoffelmeer AN, van Gaalen MM (2007) Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control. Psychopharmacology (Berl) 191:587-598. (Pubitemid 46355887)
47. Pattij T, Schetters D, Janssen MC, Wiskerke J, Schoffelmeer AN (2009) Acute effects of morphine on distinct forms of impulsive behavior in rats. Psychopharmacology (Berl) 205:489-502.
48. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Sydney: Academic.
49. Perry JL, Carroll ME (2008) The role of impulsive behavior in drug abuse. Psychopharmacology (Berl) 200:1-26.
50. Pickel VM, Chan J, Kash TL, Rodríguez JJ, MacKie K (2004) Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 127:101-112. (Pubitemid 38829156)
51. Robbins TW (2002) The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl) 163:362-380.
52. Robertson SD, Matthies HJ, Galli A (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol Neurobiol 39:73-80.
53. Roth-Deri I, Zangen A, Aleli M, Goelman RG, Pelled G, Nakash R, Gispan- Herman I, Green T, Shaham Y, Yadid G (2003) Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens. J Neurochem 84:930-938.
54. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS (2001) Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39:32-41.
55. Schachar R, Logan GD, Robaey P, Chen S, Ickowicz A, Barr C (2007) Restraint and cancellation: multiple inhibition deficits in attention deficit hyperactivity disorder. J Abnorm Child Psychol 35:229-238.
56. Schad CA, Justice JB Jr, Holtzman SG (1995) Naloxone reduces the neuro-chemical and behavioral effects of amphetamine but not those of cocaine. Eur J Pharmacol 275:9-16.
57. Schad CA, Justice JB Jr, Holtzman SG (2002) Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. J Pharmacol Exp Ther 300:932-938.
58. Schmidhammer H, Burkard WP, Eggstein-Aeppli L, Smith CF (1989) Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N- (cyclopropylmethyl)- 4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist. J Med Chem 32:418-421. (Pubitemid 19061887)
59. Schoffelmeer AN, Warden G, Hogenboom F, Mulder AH (1991) Beta-endorphin: a highly selective endogenous opioid agonist for presynaptic mu opioid receptors. J Pharmacol Exp Ther 258:237-242.
60. Seiden LS, Sabol KE, Ricaurte GA (1993) Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 33:639-677.
61. Shannon HE, Eberle EL, Mitch CH, McKinzie DL, Statnick MA (2007) Effects of kappa opioid receptor agonists on attention as assessed by a 5-choice serial reaction time task in rats. Neuropharmacology 53: 930-941.
62. Spanagel R, Herz A, Shippenberg TS (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J Neurochem 55:1734-1740.
63. Svingos AL, Moriwaki A, Wang JB, Uhl GR, Pickel VM (1997) μ-Opioid receptors are localized to extrasynaptic plasma membranes of GABAergic neurons and their targets in the rat nucleus accumbens. J Neurosci 17:2585-2594.
64. Trujillo KA, Belluzzi JD, Stein L (1991) Naloxone blockade of amphetamine place preference conditioning. Psychopharmacology (Berl) 104:265-274.
65. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN (1999) A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci 19:9579-9586.
66. van Gaalen MM, Brueggeman RJ, Bronius PF, Schoffelmeer AN, Vanderschuren LJ (2006a) Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl) 187:73-85. (Pubitemid 43876919)
67. van Gaalen MM, van Koten R, Schoffelmeer AN, Vanderschuren LJ (2006b) Critical involvement of dopaminergic neurotransmission in impulsive decision making. Biol Psychiatry 60:66-73. (Pubitemid 43912560)
68. van Gaalen MM, Unger L, Jongen-Rêlo AL, Schoemaker H, Gross G (2009) Amphetamine decreases behavioral inhibition by stimulation of dopamine D-2, but not D-3, receptors. Behav Pharmacol 20:484-491.
69. Verdejo-García A, Lawrence AJ, Clark L (2008) Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 32:777-810.
70. Wade TR, de Wit H, Richards JB (2000) Effects of dopaminergic drugs on delayed reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl) 150:90-101.
71. Waldhoer M, Bartlett SE, Whistler JL (2004) Opioid receptors. Annu Rev Biochem 73:953-990.
72. Wang JQ, McGinty JF (1995) Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res 673:262-274.
73. Wang JQ, McGinty JF (1996) D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22:114-122.
74. Winstanley CA, Dalley JW, Theobald DE, Robbins TW (2003) Global 5-HT depletion attenuates the ability of amphetamine to decrease impulsive choice on a delay-discounting task in rats. Psychopharmacology (Berl) 170:320-331.
75. Winstanley CA, Theobald DE, Dalley JW, Robbins TW (2005) Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 30:669-682.
76. Winstanley CA, Eagle DM, Robbins TW (2006) Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 26:379-395.
77. Yoshida Y, Koide S, Hirose N, Takada K, Tomiyama K, Koshikawa N, Cools AR (1999) Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors. Neuroscience 92:1357-1365. (Pubitemid 29292571)
78. Zacny JP, de Wit H (2009) The prescription opioid, oxycodone, does not alter behavioral measures of impulsivity in healthy volunteers. Pharmacol Biochem Behav 94:108-113.
79. Zadina JE, Hackler L, Ge LJ, Kastin AJ (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386:499-502. (Pubitemid 27164076)